Skip to content
Disclosery

EXANE DERIVATIVES: EXK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on EXK, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 379 EXK shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 379 shares
    Change vs previous 13F -73,230 shares

    <0.01% of the 13F portfolio, value $1,190.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 73,609 shares
    Change vs previous 13F -10,353 shares

    0.1% of the 13F portfolio, value $342,261.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 83,962 shares
    Change vs previous 13F not available

    0.09% of the 13F portfolio, value $354,307.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).